Epidemiological Study Designs: An Overview for Researchers
Epidemiological study designs are structured approaches for investigating how diseases and health-related states distribute across populations and which factors influence that distribution. For researchers in animal agriculture, veterinary science, and public health, the choice of study design determines what questions can be answered, what resources are required, and what limitations must be acknowledged in interpretation. This article provides a practical framework for understanding the major epidemiological study designs, their appropriate applications, and the decision process for selecting among them.
The Purpose of Epidemiological Study Designs
Epidemiological research seeks to understand patterns of disease occurrence and the factors that contribute to those patterns. The appropriate choice in study design is essential for the successful execution of biomedical and public health research, as each design carries specific strengths and weaknesses that must be understood to arrive at correct study conclusions [6]. Study designs were created to address the complexity of observing cause and effect in real populations, though no single design is ideal for every research question [11].
Research designs are broadly divided into observational studies, which include cross-sectional, case-control, and cohort studies, and experimental studies, which include randomized controlled trials [7]. Observational study designs, also called epidemiologic study designs, are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods [6]. Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease [6].
The final choice of design is dictated by two key factors. First is the specific research question, where questions of prevalence are best answered by cross-sectional studies, questions of harm by case-control studies, prognosis by cohort studies, and therapy by randomized controlled trials. Second is the availability of resources, including budget, time, feasibility regarding subject numbers, and research expertise [7].
Descriptive Versus Analytical Epidemiology
Epidemiological study designs can be categorized according to whether they primarily describe disease patterns or test hypotheses about associations.
Descriptive Designs
Descriptive studies characterize the distribution of disease within populations according to person, place, and time. These designs answer questions about who is affected, where disease occurs, and whether patterns change over time. Descriptive designs include case reports, case series, and cross-sectional surveys that measure disease frequency.
Case reports and case series document individual cases or small groups of cases with unusual presentations or outcomes. These designs are valuable for identifying new diseases, recognizing emerging threats, and generating hypotheses for further investigation. However, they lack comparison groups and cannot establish associations with exposures.
Cross-sectional studies measure disease status and exposure status simultaneously in a defined population at a single point in time. These studies are well suited for estimating disease prevalence and describing the distribution of health-related characteristics [10]. The cross-sectional design provides a snapshot of the population and is relatively quick and inexpensive to conduct.
Analytical Designs
Analytical studies test hypotheses about relationships between exposures and outcomes. These designs include case-control studies, cohort studies, and experimental studies. Analytical designs incorporate comparison groups that allow researchers to assess whether exposure and outcome are associated beyond what would be expected by chance.
The distinction between descriptive and analytical epidemiology matters for practical reasons. Descriptive studies can identify problems and quantify their scope, but they cannot determine what causes the problem. Analytical studies are required to evaluate potential causal relationships and to inform preventive measures [6].
Observational Study Designs
Observational studies examine relationships between exposures and outcomes without manipulating any variables. The researcher observes what occurs naturally in the population and records relevant data.
Cross-Sectional Studies
Cross-sectional studies assess exposure and outcome at the same time in a defined population. These studies are particularly useful for determining disease burden and prevalence [7]. In animal agriculture, a cross-sectional study might measure the prevalence of a respiratory pathogen in swine herds across a region at a single sampling point.
The primary advantage of cross-sectional studies is their efficiency. They require less time and fewer resources than longitudinal designs, and they can examine multiple outcomes simultaneously. The main limitation is that temporal relationships cannot be established because exposure and outcome are measured at the same time [10]. If a study finds an association between a management practice and disease presence, the researcher cannot determine whether the practice preceded the disease or resulted from it.
Cross-sectional studies are also subject to prevalence-incidence bias. Prevalent cases represent survivors of the disease process, and factors associated with survival may differ from factors associated with disease onset. This limitation is particularly relevant for chronic conditions with long duration.
Case-Control Studies
Case-control studies select participants based on outcome status. Researchers identify individuals with the disease or condition of interest, the cases, and compare them to individuals without the condition, the controls. Exposure histories are then compared between the two groups.
Case-control studies are the preferred design for questions of harm or risk factors [7]. They are especially valuable for rare diseases because they allow researchers to enroll sufficient numbers of affected individuals without following large populations over long periods. In veterinary research, a case-control study might compare management practices on farms with a confirmed disease outbreak to practices on farms without the disease.
The efficiency of case-control studies makes them attractive when resources are limited. They require smaller sample sizes than cohort studies and can be completed more quickly. However, they are susceptible to recall bias because exposure information is collected after the outcome has occurred. Selection of appropriate controls is also challenging and can introduce bias if controls are not representative of the population that produced the cases.
Cohort Studies
Cohort studies follow a defined group of individuals over time and compare outcomes between those exposed and those unexposed to a factor of interest. Cohort studies can be prospective, enrolling participants before outcomes occur, or retrospective, using existing data to reconstruct exposure status and follow outcomes.
Cohort studies are the preferred design for questions of prognosis [7]. They allow researchers to establish temporal relationships between exposures and outcomes, and they can examine multiple outcomes from a single exposure. In animal agriculture, a prospective cohort study might follow newly introduced cattle through the feedlot period to identify factors associated with bovine respiratory disease development.
The main disadvantages of cohort studies are their cost and duration. Prospective cohorts require substantial resources to maintain follow-up over extended periods. Loss to follow-up can introduce bias if participants who drop out differ systematically from those who remain. Retrospective cohorts depend on the availability and quality of historical records, which may be incomplete or inconsistently collected.
Case-Crossover Studies
Case-crossover studies are a specialized observational design in which each case serves as its own control. Exposure status at the time of the outcome event is compared to exposure status at other times for the same individual. This design is particularly useful for evaluating transient exposures that have short-term effects.
The case-crossover design eliminates confounding by stable individual characteristics because each person is compared to themselves. However, it requires careful definition of the hazard period and control periods, and it is not suitable for exposures that persist over long durations.
Ecological Studies
Ecological studies examine associations at the group level instead of the individual level. Disease rates and exposure levels are compared across populations or geographic areas. These studies are useful for generating hypotheses and for evaluating population-level interventions.
The primary limitation of ecological studies is the ecological fallacy, where associations observed at the group level do not necessarily reflect associations at the individual level. Ecological studies cannot control for confounding at the individual level and should be interpreted with caution.
Experimental Study Designs
Experimental studies involve active manipulation of exposures by the researcher. Participants are assigned to receive or not receive an intervention, and outcomes are compared between groups.
Randomized Controlled Trials
Randomized controlled trials are the preferred design for questions of therapy or intervention effectiveness [7]. Participants are randomly assigned to treatment or control groups, which balances both known and unknown confounding factors across groups when sample sizes are adequate.
The randomized controlled trial is considered the gold standard for evaluating intervention effects because randomization minimizes the influence of confounding variables. Blinding, where participants and researchers do not know treatment assignment, further reduces bias. In animal research, randomized controlled trials might evaluate vaccine efficacy, treatment protocols, or management interventions.
Randomized controlled trials require substantial resources and are not always feasible or ethical [7]. They may be impractical for rare diseases because enrolling sufficient numbers of affected animals is difficult. They may be unethical when the intervention is potentially harmful or when withholding a known effective treatment would harm participants.
Randomized Crossover Trials
Randomized crossover trials assign participants to receive multiple interventions in sequence, with each participant serving as their own control. This design increases statistical efficiency because within-subject comparisons eliminate between-subject variability.
Crossover trials are appropriate when the effects of the intervention are reversible and when carryover effects can be adequately controlled through washout periods. They are not suitable for interventions with lasting effects or for conditions that change substantially over time.
Quasi-Experimental Trials
Quasi-experimental trials assign groups to interventions without randomization. These designs are used when randomization is not feasible or ethical. Examples include before-and-after studies and non-randomized controlled trials.
Quasi-experimental designs are more susceptible to confounding than randomized trials because treatment assignment may be related to prognostic factors. However, they can provide useful evidence when randomized trials are impossible. The Journal of Educational Evaluation for Health Professions analysis found that before-and-after studies and non-randomized trials were among the designs most frequently suggested for reclassification to more suitable designs, highlighting the importance of careful design selection [25].
Diagnostic Study Designs
An important subset of observational studies is diagnostic study designs, which evaluate the accuracy of diagnostic procedures and tests as compared to other diagnostic measures [6]. These include diagnostic accuracy designs, diagnostic cohort designs, and diagnostic randomized controlled trials [6].
Diagnostic accuracy studies compare a new test to a reference standard in a sample of subjects. Diagnostic cohort studies follow a defined population to evaluate test performance in a realistic clinical context. Diagnostic randomized controlled trials compare outcomes when different diagnostic strategies are used to guide management.
These designs are essential for validating diagnostic tools used in veterinary practice and disease surveillance. A diagnostic accuracy study might evaluate a new point-of-care test for a production-limiting disease against polymerase chain reaction as the reference standard.
Selecting the Appropriate Study Design
The selection of a study design should follow a systematic process that begins with a clearly defined research question and considers available resources and constraints.
Step 1: Define the Research Question
Articulate the research question in terms of the population, exposure or intervention, comparison, and outcome. Determine whether the question addresses prevalence, risk factors, prognosis, or treatment effectiveness. This classification directly guides design selection [7].
Step 2: Classify the Question Type
Questions of disease burden and prevalence are best answered by cross-sectional studies. Questions of harm or risk factors are best answered by case-control studies. Questions of prognosis are best answered by cohort studies. Questions of therapy are best answered by randomized controlled trials [7].
Step 3: Assess Feasibility
Evaluate the resources available for the study, including budget, time, access to study populations, and research expertise [7]. Randomized controlled trials require substantial resources and may be unethical or impractical in many situations [7]. Rare diseases may not have sufficient cases for efficient cohort studies, making case-control designs more appropriate.
Step 4: Consider Ethical Constraints
Randomized trials are not appropriate when the intervention is potentially harmful or when withholding treatment would be unethical [7]. Observational designs may be the only ethical option for studying harmful exposures or for conditions where treatment cannot be withheld.
Step 5: Evaluate Data Availability
Retrospective designs depend on existing data sources. Population-based databases such as the Surveillance, Epidemiology, and End Results program provide comprehensive information for cancer research, though the huge data volume and complexity of data types can hinder application [9]. Researchers should assess the quality, completeness, and accessibility of available data before selecting a retrospective design.
Step 6: Plan for Reporting Standards
Reporting guidelines improve the transparency and quality of research reports. The EQUATOR Network provides access to reporting guidelines for various study designs [2]. Researchers should identify the appropriate reporting guideline for their chosen design and consult it during study planning.
At a Glance: Epidemiological Study Design Comparison
| Design | Primary Question | Key Strengths | Key Limitations | Resource Demand |
|---|---|---|---|---|
| Cross-sectional | What is the prevalence or burden of disease? | Quick and inexpensive, measures multiple outcomes, good for planning | Cannot establish temporal sequence, susceptible to prevalence-incidence bias | Low |
| Case-control | What factors are associated with disease (harm)? | Efficient for rare diseases, smaller sample size, faster completion | Recall bias, control selection challenges, cannot measure incidence | Low to moderate |
| Cohort | What is the prognosis or natural history of disease? | Establishes temporal sequence, measures incidence, examines multiple outcomes | Expensive, long duration, loss to follow-up, inefficient for rare diseases | High |
| Randomized controlled trial | Does the intervention work (therapy)? | Minimizes confounding through randomization, strongest causal evidence | Expensive, may be unethical or impractical, limited generalizability | Very high |
Practical Implementation Steps for Design Selection
Step 1: Write the Research Question Explicitly
Write the research question in a single sentence that specifies the population, exposure, comparison, and outcome. Test whether the question can be answered with the resources available. If the question asks about prevalence, a cross-sectional design is appropriate. If it asks about therapy, a randomized controlled trial is needed [7].
Step 2: Review Existing Literature
Search PubMed and other literature databases to understand what is already known about the research question [5]. The National Center for Biotechnology Information provides access to literature resources for this purpose [4]. Identify gaps in knowledge and determine whether the proposed study would add meaningful information.
Step 3: Inventory Available Resources
List the budget, personnel, time, and access to study populations. Estimate the sample size required for the design under consideration. If the required sample size exceeds what is feasible, consider a different design or narrow the research question.
Step 4: Consult Design Tools
The NC3Rs Experimental Design Assistant provides guidance for designing experiments and identifying potential sources of bias [3]. This tool can help researchers plan studies that minimize bias and maximize the reliability of results.
Step 5: Select the Design and Document Justification
Select the design that best answers the research question within the constraints of available resources. Document the rationale for the design choice, including why alternative designs were rejected. This documentation supports transparency and helps reviewers understand the study context.
Step 6: Identify the Appropriate Reporting Guideline
Consult the EQUATOR Network to identify the reporting guideline for the selected design [2]. Follow the guideline during study planning and manuscript preparation to ensure complete and transparent reporting.
Records and Measurements in Epidemiological Studies
Accurate measurement is fundamental to the validity of epidemiological studies. Researchers must define how exposures and outcomes will be measured and must document the validity and reliability of measurement instruments.
Exposure Measurement
Exposure measurement should be standardized across study participants. In observational studies, exposure information may come from questionnaires, biological samples, environmental monitoring, or existing records. The method of exposure assessment should be described in sufficient detail that other researchers could replicate it.
Measurement error in exposure assessment can bias results toward the null, making it more difficult to detect true associations. Researchers should assess the validity of exposure measures and acknowledge limitations in interpretation.
Outcome Ascertainment
Outcome definitions should be explicit and applied consistently. In animal agriculture, outcomes might include clinical disease, mortality, production parameters, or laboratory-confirmed infection. The choice of outcome definition affects the comparability of results across studies.
The systematic review of Mycoplasma synoviae infection in chickens in mainland China demonstrated the importance of outcome ascertainment methods. The review found a high serological prevalence coexisting with a moderate molecular detection prevalence, reflecting widespread past exposure, chronic carrying, or vaccination [14]. This diagnostic disparity highlights how different measurement approaches can produce different prevalence estimates and how interpretation must account for the characteristics of each method.
Data Quality Control
Quality control procedures should be implemented throughout the data collection process. These procedures include standardized training for data collectors, regular calibration of equipment, and verification of data entry. The Research Data Framework from the National Institute of Standards and Technology provides guidance on managing research data to ensure quality and reproducibility [1].
Documentation Standards
Complete documentation of study procedures supports reproducibility and allows readers to assess the validity of study findings. Documentation should include the study protocol, data collection instruments, and analysis code. The Research Data Framework addresses the infrastructure needed to support research data management [1].
Common Failure Patterns in Epidemiological Studies
Understanding common failure patterns helps researchers avoid errors in study design and interpretation.
Confounding
Confounding occurs when a third variable is associated with both the exposure and the outcome and is not on the causal pathway between them. Confounding can create spurious associations or mask true associations. The review of environmental risk factors for autism noted that mechanisms of association might include non-causative association including confounding [12].
Confounding is controlled through randomization, restriction, matching, or statistical adjustment. Researchers should identify potential confounders during the design phase and plan appropriate control strategies.
Selection Bias
Selection bias occurs when the study population is not representative of the target population. This bias can arise from non-random selection of participants, differential loss to follow-up, or non-response. Selection bias threatens the external validity of study findings.
In case-control studies, selection of controls is a common source of bias. Controls should be selected from the same population that produced the cases, and selection should be independent of exposure status.
Information Bias
Information bias results from systematic errors in measuring exposure or outcome. Recall bias occurs when cases remember exposures differently than controls. Observer bias occurs when researchers assess outcomes differently based on knowledge of exposure status. The review of study designs noted that lapses in validity can be introduced through confounding, selection, and information biases [11].
Misclassification
Misclassification occurs when subjects are assigned to the wrong exposure or outcome category. Non-differential misclassification, where errors are unrelated to other study variables, typically biases results toward the null. Differential misclassification, where errors are related to other study variables, can bias results in either direction.
Missing Data
Missing data are common in epidemiological studies, particularly in retrospective designs that depend on existing records. The analysis of study designs in PubMed prisoner health abstracts found that study design details were missing from many abstracts, limiting the ability to assess research quality [23]. Researchers should plan for missing data and use appropriate statistical methods to handle it.
Limitations of Epidemiological Study Designs
Each study design has potential limitations that are more severe and need to be addressed in the design phase of the study [6]. Researchers should acknowledge these limitations and take steps to minimize their impact.
Limitations of Observational Studies
Observational studies cannot establish causation with the same certainty as randomized trials because confounding cannot be fully controlled. The review of environmental risk factors for autism noted that studies on toxic elements were largely limited by their design [12]. Observational studies are also susceptible to various biases that can distort associations.
Limitations of Experimental Studies
Randomized controlled trials have limitations related to generalizability, cost, and feasibility. Trial participants may not represent the broader population, and trial conditions may not reflect real-world practice. The analysis of cancer clinical trial activity in European Union countries found that clinical trial activity varied considerably across countries and that commercial trials were consistently more common than non-commercial trials [17]. This variation in trial activity may not reflect the true epidemiological burden of disease.
Limitations of Retrospective Designs
Retrospective studies depend on the availability and quality of historical data. The review of SEER database applications noted that the intrinsic features of the database, such as the huge data volume and complexity of data types, have hindered its application [9]. Researchers using existing databases must understand the data structure and limitations before conducting analyses.
Limitations of Spatial and Modeling Approaches
Spatial epidemiological models have become increasingly important for understanding disease transmission. The systematic review of spatial epidemiological modeling approaches applied during the COVID-19 pandemic identified a Geography, Population, Movement framework that conceptualizes the interactions between three distinct subcomponents of any spatial model [18]. These models require specialized expertise and are subject to assumptions that may not hold in all settings.
Welfare and Safety Context in Animal Research
Epidemiological research involving animals must consider animal welfare and research ethics. Studies should be designed to minimize animal suffering and to use the minimum number of animals necessary to answer the research question.
Ethical Review
Research protocols involving animals should be reviewed by institutional animal care and use committees or equivalent oversight bodies. The review should assess the scientific merit of the study, the justification for animal use, and the adequacy of measures to minimize pain and distress.
Experimental Design for Animal Studies
The NC3Rs Experimental Design Assistant supports the design of animal experiments that are robust and reliable while minimizing animal use [3]. Researchers should use this tool to plan experiments that will produce valid results with the minimum number of animals.
Reporting Standards for Animal Research
Reporting guidelines for animal research improve the transparency and reproducibility of studies. The EQUATOR Network provides access to these guidelines [2]. Researchers should follow the appropriate reporting guideline for their study design.
Professional Escalation Criteria
Researchers should recognize when a study design is not appropriate for the research question and when additional expertise is needed.
When to Consult a Biostatistician or Epidemiologist
Consult a biostatistician or epidemiologist when the research question involves complex relationships, when sample size calculations are uncertain, or when the analysis plan requires specialized methods. Early consultation during the design phase is more effective than seeking help after data collection is complete.
When to Reconsider the Study Design
Reconsider the study design when the required sample size exceeds available resources, when ethical constraints prevent the planned intervention, or when the research question cannot be answered with the available data. The analysis of study designs in the Journal of Educational Evaluation for Health Professions found that some articles were suggested to be described with more suitable study designs, particularly before-and-after studies, diagnostic research, and non-randomized trials [25]. This finding emphasizes the importance of careful design selection.
When to Escalate to Institutional Review
Escalate to institutional review when the study involves vulnerable populations, when the intervention carries significant risk, or when the study raises ethical concerns that cannot be resolved by the research team. Institutional review provides oversight and ensures that studies meet ethical standards.
Frequently Asked Questions
What is the difference between observational and experimental study designs?
Observational studies examine relationships between exposures and outcomes without manipulating any variables, while experimental studies involve active manipulation of exposures by the researcher [6]. Observational designs include cross-sectional, case-control, and cohort studies, while experimental designs include randomized controlled trials and quasi-experimental trials [7]. Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships, while interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease [6].
When should I use a cross-sectional study design?
Use a cross-sectional study when the research question concerns disease prevalence or burden [7]. Cross-sectional studies measure exposure and outcome at the same time in a defined population and are relatively quick and inexpensive to conduct [10]. They are appropriate for planning health services and for describing the distribution of health-related characteristics. However, they cannot establish temporal relationships because exposure and outcome are measured simultaneously [10].
When should I use a case-control study design?
Use a case-control study when the research question concerns harm or risk factors, particularly for rare diseases [7]. Case-control studies select participants based on outcome status and compare exposure histories between cases and controls. They are efficient because they require smaller sample sizes than cohort studies and can be completed more quickly. However, they are susceptible to recall bias and require careful selection of controls.
When should I use a cohort study design?
Use a cohort study when the research question concerns prognosis or the natural history of disease [7]. Cohort studies follow a defined group over time and compare outcomes between exposed and unexposed individuals. They establish temporal relationships and can measure incidence. However, they are expensive and require long follow-up periods, making them inefficient for rare diseases [7].
When should I use a randomized controlled trial?
Use a randomized controlled trial when the research question concerns therapy or intervention effectiveness [7]. Randomization balances known and unknown confounding factors across groups, providing the strongest evidence for causal relationships. However, randomized controlled trials require substantial resources and may be unethical or impractical in many situations [7]. They are not appropriate when the intervention is potentially harmful or when withholding treatment would be unethical.
What is the ecological fallacy and why does it matter?
The ecological fallacy occurs when associations observed at the group level are incorrectly assumed to apply at the individual level. Ecological studies examine associations at the group level instead of the individual level, and the ecological fallacy is a primary limitation of this design. Researchers should be cautious when interpreting ecological study results and should not draw individual-level conclusions from group-level data.
How do I choose between a prospective and retrospective cohort study?
Choose a prospective cohort when you need to collect exposure information before outcomes occur and when you can follow participants forward in time. Choose a retrospective cohort when historical data are available and when the outcome has already occurred. Retrospective cohorts depend on the quality and completeness of existing records, which may be limited [9]. Prospective cohorts require more time and resources but allow more control over data collection.
What are reporting guidelines and why should I use them?
Reporting guidelines are checklists that specify the minimum information needed for a complete and transparent report of a study. The EQUATOR Network provides access to reporting guidelines for various study designs [2]. Using reporting guidelines improves the quality of research reports and helps readers assess the validity of study findings. The analysis of articles in the Journal of Educational Evaluation for Health Professions found that some reporting guidelines were used inappropriately, highlighting the need for education and training on study design and reporting guidelines [25].
Related Articles
- Observational Vs Experimental Study
- Observational Vs Experimental Study
- Observational Vs Experimental Study
- Experimental Research Sample
- Experimental Research Sample
References and Further Reading
- Research Data Framework. National Institute of Standards and Technology.
- EQUATOR Network. EQUATOR Network.
- Experimental Design Assistant. NC3Rs.
- NCBI Literature Resources. National Center for Biotechnology Information.
- PubMed. National Library of Medicine.
- Observational and interventional study design types, an overview.. Biochemia medica, 2014.
- How to choose your study design.. Journal of paediatrics and child health, 2020.
- Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework.. BMC health services research, 2017.
- How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology.. Military Medical Research, 2023.
- Study design III: Cross-sectional studies.. Evidence-based dentistry, 2006.
- Overview of Study Designs: A Deep Dive Into Research Quality Assessment.. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2021.
- Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses.. Molecular autism, 2017.
- Dermatoepidemiology.. Journal of the American Academy of Dermatology, 2005.
- Prevalence and Epidemiological Characteristics of <,i>,Mycoplasma synoviae<,/i>, Infection in Chickens in Mainland China.. 2026.
- Diversity at the Acinetobacter baumannii K locus: towards a comprehensive in silico database for prediction of capsular polysaccharide types. 2026.
- Prevalence and Epidemiological Characteristics of Mycoplasma synoviae Infection in Chickens in Mainland China. 2026.
- Mismatch Between Cancer Burden and Clinical Trial Activity in the European Union: Analysis of Incidence, per Capita Indicators and Commercial Versus Non-Commercial Studies.. 2026.
- A systematic review of spatial epidemiological modeling approaches applied during the COVID-19 pandemic.. 2026.
- Prevalence and genotype distribution of human papillomavirus in Sulaymaniyah, Kurdistan Region, Iraq.. 2026.
- Overview of Epidemiological Study Designs. 2018.
- ON EPIDEMIOLOGICAL STUDY DESIGNS. 2015.
- Research challenges: overview of epidemiological study designs.. Journal of Rheumatology Supplement, 1988.
- An analysis of published study designs in PubMed prisoner health abstracts from 1963 to 2023: a text mining study. BMC Medical Research Methodology, 2024.
- Statistical Issues in Research I: Overview of Epidemiological Study Design. 2015.
- Suggestion of more suitable study designs and the corresponding reporting guidelines in articles published in the Journal of Educational Evaluation for Health Professions from 2021 to September 2022: a descriptive study. Journal of Educational Evaluation for Health Professions, 2022.
- Epidemiological Study Designs: An Overview. Basic Principles of Epidemiology Second Edition, 2026.
- Research challenges: Overview of epidemiological study designs. Journal of Rheumatology, 1988.
- Standard designs of epidemiological studies and their chaacteristics in ophthalmology. Klinische Monatsblatter Fur Augenheilkunde, 2002.
- Epidemiological research on migrant health in Germany. An overview. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2006.
- Interstitial lung diseases: An epidemiological overview. European Respiratory Journal Supplement, 2001.
This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.